| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
0.9 |
| mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |
| mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
1 |
| mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
1 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
| mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
| mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |